This story on breast reduction surgery is triggered by news reports about Simona Halep, a Romanian tennis player whose breasts are so large they reportedly affect her performance on court. While this has launched predictably vulgar chatter around the Internet, it does create something of a "teachable moment" on the topic of macromastia, as the condition of excessive breast size is known.
Alas, the Daily News isn’t quite up for the challenge.
On the positive side, the reporter did talk to four breast surgery specialists and provides a basic explanation of the condition. The reader essentially learns that macromastia can be serious–that it causes pain, limits activity and can be treated with surgery.
On the negative side:
The story’s rosy view of the surgery is likely to have been shaped by the enthusiasm of the four plastic surgeons used as sources, one of whom has "his" own technique, called the "lollipop lift." All have economic self-interest in seeing breast reduction surgery portrayed as medically important and highly effective. The story has conveyed this viewpoint without resistance.
[Curiously, all of the sources are men.]
A reader is likely to exit this story with plenty of questions: How successful is the surgery, and how long-lasting are the symptoms? At what point does breast size become a treatable condition? At what point do the benefits of surgery outweigh the risks? Is this problem best treated early to prevent chronic pain from settling in?
Alas, the story doesn’t explore any of these questions.
And it can’t go without a final mention: Comparing the symptoms of excessively large breasts to those of metastatic cancer is just shameful.
The story fails to mention the cost of breast reduction, which ranges from $6,000 to $10,000.
The story includes the fact that insurance sometimes pays. But readers would be curious to know what might qualify/disqualify women for coverage.
The story describes the benefits of breast reduction surgery but does not use any data to quantify the frequency or magnitude of the benefit.
The story fails to mention the risks of breast reduction surgery, which are considerable: infection, bleeding, blood clots, nerve and muscle damage, plus the risks associated with anesthesia.
Further, the story fails to mention a risk of great importance to younger women: inability to breastfeed.
The story does not cite any evidence of rates of pain reduction and increased mobility.
The story quotes a doctor who compares the pain of macromastia to the pain suffered by someone with metastatic cancer of the spine.
This is a shamefully sensational exaggeration. It is completely unnecessary to make the point that macromastia is a serious and debilitating condition.
The story includes comments from four plastic surgeons linked to credible institutions.
Having said that, all of the sources are biased in favor of the procedure for reasons of economic self-interest.
It’s also worth noting that all four are men.
The story quotes a specialist saying that women with macromastia who do not have surgery can wear special reinforced bras, sports bras or even two bras, and can treat pain with analgesics and rashes with ointments.
The story states that 140,000 women per year get breast reduction surgery. This clearly implies wide availability.
The story makes plain that the surgery is commonly done and makes no claim for its novelty.
There does not appear to be a press release linked to this story.
Systematic, Criteria-Driven
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like